Development of Egg Albumin Microspheres for Diltiazem Hydrochloride
Author Information
Author(s): Shailesh TP, Vipul PD, Girishbhai JK, Manish CJ
Primary Institution: Shri Sarvajanik Pharmacy College, Mehsana, Gujarat, India
Hypothesis
The study aims to develop sustained release ethylcellulose-coated egg albumin microspheres of diltiazem hydrochloride to improve patient compliance.
Conclusion
Ethylcellulose-coated egg albumin microspheres are suitable for oral sustained release devices in treating angina pectoris, cardiac arrhythmias, and hypertension.
Supporting Evidence
- The optimized formulation showed a high drug entrapment efficiency of 79.20%.
- Initial burst release of 55% of the drug occurred within the first hour.
- The microspheres provided a slow release of the drug for 8-10 hours.
Takeaway
The researchers created tiny balls filled with a heart medication that can be taken less often, making it easier for patients to stick to their treatment.
Methodology
Microspheres were prepared using a w/o emulsion thermal cross-linking method and optimized using a 32 full factorial design.
Limitations
Not all batches met the ideal drug release criteria, and the study did not evaluate long-term clinical outcomes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website